This chapter explores the repercussions of escalating drug prices on consumers, emphasizing the role of government and private insurance in covering these costs. It delves into the complex distribution channels and the disparities between drug pricing in the US and other countries, shedding light on the exploitation and profit-making at the expense of taxpayers and premium holders.